Richard E. Lowenthal
PRESIDENT AND CEO at ARS Pharmaceuticals. Based in San Diego, California.
- Rank
- 3834th of 14,644
- Companies held
- 1
- Largest holding
- SPRY, 100.0% of total
- Latest SEC filing
- Aug 21, 2025
- Listed but not counted
- $19.7M
What the $29.4M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ARS Pharmaceuticals SPRY Common Stock | Through Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006 Reported jointly by 2 insiders; split evenly | 4,429,600 | $3.36 | $14.9M | 50.6% | Form 4, Aug 21, 2025 |
| ARS Pharmaceuticals SPRY Common Stock | Directly | 4,327,189 | $3.36 | $14.5M | 49.4% | Form 4, Dec 17, 2024 |
Share counts are the amounts Richard E. Lowenthal reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Richard E. Lowenthal's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| ARS Pharmaceuticals SPRY Common Stock | Through Spouse Counted on the profile of the insider who holds these shares directly | 3,433,512 | $3.36 | $11.5M | — | Form 4, Dec 17, 2024 |
| ARS Pharmaceuticals SPRY Common Stock | Through Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020 Held for a foundation or charity | 1,247,447 | $3.36 | $4.2M | — | Form 4, Aug 21, 2025 |
| ARS Pharmaceuticals SPRY Common Stock | Through Richard E. Lowenthal Charitable Remainder UniTrust Dated January 7, 2020 Held for a foundation or charity | 1,196,494 | $3.36 | $4.0M | — | Form 4, Aug 21, 2025 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3831 | Andrea Jung Director, Apple. Boston, MA | $29.4M |
| 3832 | John C. Butler Jr. President & CEO, NACCO Industries. Glen Allen, VA | $29.4M |
| 3833 | Christopher Sorrells Director, General Fusion Group | $29.4M |
| 3834 | Richard E. Lowenthal PRESIDENT AND CEO, ARS Pharmaceuticals. San Diego, CA | $29.4M |
| 3835 | Daniel Lau 10% owner, Gran Tierra Energy | $29.4M |
| 3836 | Robert W. Eddy President & CEO, BJ's Wholesale Club Holdings. Marlborough, MA | $29.4M |
| 3837 | Nestor Cano EVP, Transformation and CIDO, T-Mobile US. Bellevue, WA | $29.4M |
Other ARS Pharmaceuticals insiders
All SPRY insiders- Sarina Tanimoto$26.4MCHIEF MEDICAL OFFICER. #4187 overall
- Pratik Shah$15.0MDirector. #6434 overall
- Jonathan D. Root$320KDirector. #7684 overall
Questions
How much stock does Richard E. Lowenthal own?
Richard E. Lowenthal holds $29,422,811 in listed stock based on SEC filings and current prices, mostly ARS Pharmaceuticals (SPRY). That ranks 3834th on the Stock Rich List.
Is this Richard E. Lowenthal's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.